StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27+0.00 (+0.37%)

Close on Nov 18, 2026Market cap $2.89MP/E –Yield –

Gelteq revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was A$165.65K, up 107.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$165.65K+107.5%
FY2023Jun 30, 2023A$79.84K–

More Gelteq figures

See a number that looks wrong?